Category: health
Our mission is to provide health care tips empowering, evidence-based information that you can use to help yourself and your loved ones. Our health blogs help you help yourself by offering guidance and encouragement. By following our blogs you will start feeling better. We aim to provide articles that give the audience better information that can improve their lives. Our blogs cover topics such as health, fitness and their supplements. Also, it focuses on the essential things you need to know to understand the problem you’re facing, make informed decisions, and take positive steps. We deliver our readers a better online experience. Read on!
PE funds: Outsourcing majors, PE funds in fray for Everise
[ad_1] Mumbai: Global outsourcing firms such as Accenture and Teleperformance are competing with a clutch of private equity funds for potential acquisition of global ITeS firm Everise. The company, backed by Brookfield Asset Management, is expected to be valued at $1.3 billion, said multiple people aware of the development. Investment banks Morgan Stanley and BNP ...
covid: Non-communicable diseases bigger issue than Covid: Apollo JMD Sangita Reddy
[ad_1] Spread of non-communicable diseases like cancer, diabetes, and heart problems in the country is an even bigger issue than the Covid pandemic, according to Apollo Hospitals Joint Managing Director Sangita Reddy. In an interaction with PTI on the sidelines of an event here, she noted that maintaining health parameters in order is the single ...
MedGenome, backed by Sequoia Capital, acquires Delhi-NCR based Prognosis Laboratories
[ad_1] MedGenome on Friday acquired Delhi-NCR based diagnostic lab Prognosis Laboratories. The financial details of the acquisition were not disclosed. The acquisition will help Bengaluru-based MedGenome to accelerate growth and geographic penetration. “The transaction augments MedGenome’s comprehensive diagnostic portfolio, foothold in Northern India, coupled with complementary business models and natural synergies to drive growth and ...
Investors in Aster DM look to pare their stake in hospital biz
[ad_1] Foreign institutional investors in Aster DM Healthcare, the listed Indian arm controlled by the UAE-based hospital conglomerate by the same name, are looking to offload 30% of their stake in the Indian healthcare business for about $300 million, reports say. Investors in the Bengaluru-headquartered hospital chain are in talks with private equity fund KKR ...
IndiaRF eyes a controlling stake in Punjab’s Ivy Hospital
[ad_1] Mumbai: India Resurgence Fund (IndiaRF), an India-focused distressed and special situations investment platform sponsored by the Piramal group and Bain Capital Credit, is in talks with Punjab-based hospital chain Ivy Hospital to pick up a controlling stake in the company at a valuation of over ₹1,000 crore, said two people aware of the development. ...
mandaviya: India’s pharma sector robust, met both local and global demand during pandemic: Mansukh Mandaviya
[ad_1] India‘s pharmaceutical industry is robust and resilient and that is exactly why it could not only meet its own demand during the pandemic but also was in a position to supply medicines to 150 countries, Union Minister of Health and Family Welfare Mansukh Mandaviya as he inaugurated the 8th International Conference on Pharma and ...
US-based StemCures to set up India’s largest stem cell manufacturing lab in Hyderabad
[ad_1] US-based StemCures will establish a manufacturing lab in Telangana with a focus on stem cell therapy to create the largest stem cell manufacturing plant in India. An official release from the Telangana government on Wednesday said the facility will be set up with the investment potential of around USD 54 million and employment potential ...
Biocon Biologics may raise additional equity of $300 million in FY24 to pare debt
[ad_1] Biocon Biologics is looking to raise additional equity of $300 million by end of FY24 as it plans to further pare debt it has accumulated to fund the $3.3 billion acquisition of Viatris’ biosimilar business. “We might want to take it another, maybe, maximum $300 million, so once we do that, we are in ...
Cipla vows to crack diabetes segment with licensed branded portfolio
[ad_1] Drugmaker Cipla is giving a major thrust to the highly competitive diabetes segment, led by investments on building product portfolio, field force expansion and focus on making brands bigger. “Cipla historically has always been a big respiratory and acute player but not that big in the diabetes area,” said Umang Vohra, managing director and ...
Medical device packs will have to display key info
[ad_1] All medical devices will have to bear details like retail price, country of origin, size and dimensions and consumer care details on the package so that consumers can make an informed decision, the department of consumer affairs has said. In a letter to the department of pharmaceuticals (DOP), the department of consumer affairs has ...